These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 18598056)

  • 21. Two pyridine derivatives as potential Cu(II) and Zn(II) chelators in therapy for Alzheimer's disease.
    Lakatos A; Zsigó E; Hollender D; Nagy NV; Fülöp L; Simon D; Bozsó Z; Kiss T
    Dalton Trans; 2010 Feb; 39(5):1302-15. PubMed ID: 20104357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in Alzheimer's disease.
    Rodríguez-Rodríguez C; Sánchez de Groot N; Rimola A; Alvarez-Larena A; Lloveras V; Vidal-Gancedo J; Ventura S; Vendrell J; Sodupe M; González-Duarte P
    J Am Chem Soc; 2009 Feb; 131(4):1436-51. PubMed ID: 19133767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding affinities for models of biologically available potential Cu(II) ligands relevant to Alzheimer's disease: an ab initio study.
    Rickard GA; Gomez-Balderas R; Brunelle P; Raffa DF; Rauk A
    J Phys Chem A; 2005 Sep; 109(37):8361-70. PubMed ID: 16834228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of clioquinol on metal-triggered amyloid-beta aggregation revisited.
    Mancino AM; Hindo SS; Kochi A; Lim MH
    Inorg Chem; 2009 Oct; 48(20):9596-8. PubMed ID: 19817493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
    Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
    Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide.
    Faller P; Hureau C
    Dalton Trans; 2009 Feb; (7):1080-94. PubMed ID: 19322475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct evidence that all three histidine residues coordinate to Cu(II) in amyloid-beta1-16.
    Shin BK; Saxena S
    Biochemistry; 2008 Sep; 47(35):9117-23. PubMed ID: 18690709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual functions of beta-amyloid oligomer and fibril in Cu(II)-induced H2O2 production.
    Fang CL; Wu WH; Liu Q; Sun X; Ma Y; Zhao YF; Li YM
    Regul Pept; 2010 Aug; 163(1-3):1-6. PubMed ID: 20478342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alanine-2 carbonyl is an oxygen ligand in Cu2+ coordination of Alzheimer's disease amyloid-beta peptide--relevance to N-terminally truncated forms.
    Drew SC; Masters CL; Barnham KJ
    J Am Chem Soc; 2009 Jul; 131(25):8760-1. PubMed ID: 19496610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metal loading ability of beta-amyloid N-terminus: a combined potentiometric and spectroscopic study of copper(II) complexes with beta-amyloid(1-16), its short or mutated peptide fragments, and its polyethylene glycol (PEG)-ylated analogue.
    Damante CA; Osz K; Nagy Z; Pappalardo G; Grasso G; Impellizzeri G; Rizzarelli E; Sóvágó I
    Inorg Chem; 2008 Oct; 47(20):9669-83. PubMed ID: 18808108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.
    Dikalov SI; Vitek MP; Mason RP
    Free Radic Biol Med; 2004 Feb; 36(3):340-7. PubMed ID: 15036353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural studies of the Alzheimer's amyloid precursor protein copper-binding domain reveal how it binds copper ions.
    Kong GK; Adams JJ; Harris HH; Boas JF; Curtain CC; Galatis D; Masters CL; Barnham KJ; McKinstry WJ; Cappai R; Parker MW
    J Mol Biol; 2007 Mar; 367(1):148-61. PubMed ID: 17239395
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron.
    Nakamura M; Shishido N; Nunomura A; Smith MA; Perry G; Hayashi Y; Nakayama K; Hayashi T
    Biochemistry; 2007 Nov; 46(44):12737-43. PubMed ID: 17929832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abeta-mediated ROS production by Cu ions: structural insights, mechanisms and relevance to Alzheimer's disease.
    Hureau C; Faller P
    Biochimie; 2009 Oct; 91(10):1212-7. PubMed ID: 19332103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methionine regulates copper/hydrogen peroxide oxidation products of Abeta.
    Ali FE; Separovic F; Barrow CJ; Cherny RA; Fraser F; Bush AI; Masters CL; Barnham KJ
    J Pept Sci; 2005 Jun; 11(6):353-60. PubMed ID: 15635660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of chelators and iron ions on the production and degradation of H2O2 by beta-amyloid-copper complexes.
    Deraeve C; Pitie M; Meunier B
    J Inorg Biochem; 2006 Dec; 100(12):2117-26. PubMed ID: 17011628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of quercetin with iron and copper ions: complexation and autoxidation.
    El Hajji H; Nkhili E; Tomao V; Dangles O
    Free Radic Res; 2006 Mar; 40(3):303-20. PubMed ID: 16484047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-Terminal deletions modify the Cu2+ binding site in amyloid-beta.
    Karr JW; Akintoye H; Kaupp LJ; Szalai VA
    Biochemistry; 2005 Apr; 44(14):5478-87. PubMed ID: 15807541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.